IndraLab

Statements

TNFAIP3 decreases the amount of CDKN2A. 1 / 1

| 1

reach

"Whereas ABC DLBCL is characterized by frequent mutations in nuclear factor-kappaB (NF-kappaB) pathway drivers and intermediates, including TNFAIP3, MYD88, CARD11 and CD79B, as well as loss of cell cycle regulators CDKN2A and CDKN2B, GCB DLBCL carry frequent mutations in epigenetic modifiers, such as CREBBP, KMT2D and EZH2."

| PMC

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

TNFAIP3 decreases the amount of CDKN2A. 1 / 1

INDRA sources:

Databases

Reading